Cargando…

Prolonged Disease Course of COVID-19 in a Patient with CTLA-4 Haploinsufficiency

Patients with primary immunodeficiencies are especially vulnerable to developing severe coronavirus disease 2019 (COVID-19) after infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Cytotoxic T lymphocyte antigen-4 (CTLA-4) is an important regulator of immune responses,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoffman, T. W., Leavis, H. L., Smits, B. M., van der Veken, L. T., van Kessel, D. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228224/ https://www.ncbi.nlm.nih.gov/pubmed/37260564 http://dx.doi.org/10.1155/2023/3977739

Ejemplares similares

A case of autoimmune enteropathy with CTLA4 haploinsufficiency
por: Miyazaki, Haruka, et al.
Publicado: (2022)

Pitfalls of immunotherapy: lessons from a patient with CTLA-4 haploinsufficiency
por: Watson, Leisa Rebecca, et al.
Publicado: (2018)

Granulomatous interstitial nephritis with CTLA-4 haploinsufficiency: a case report
por: Kohatsu, Kaori, et al.
Publicado: (2022)

Two neurologic facets of CTLA4-related haploinsufficiency
por: Ayrignac, Xavier, et al.
Publicado: (2020)

Autoimmune manifestations of CTLA-4 haploinsufficiency in two patients of Southeast Asian ethnicity
por: Lim, Xin Rong, et al.
Publicado: (2023)

CTLA-4 Haploinsufficiency Presenting as Extensive Enteropathy in a Patient With Very Early Onset Inflammatory Bowel Disease
por: Tran, Ngoc N., et al.
Publicado: (2021)

A Family with a Novel CTLA4 Haploinsufficiency Mutation and Neurological Symptoms
por: Grammatikos, Alexandros, et al.
Publicado: (2021)

A sporadic case of CTLA4 haploinsufficiency manifesting as Epstein–Barr virus-positive diffuse large B-cell lymphoma
por: Yuan, Hepei, et al.
Publicado: (2021)

MON-155 A Patient with Acquired Generalized Lipodystrophy (AGL, Lawrence Syndrome) in Association with CTLA-4 Haploinsufficiency
por: Ozer, Muhammet, et al.
Publicado: (2019)

Haploinsufficiency of Akt1 Prolongs the Lifespan of Mice
por: Nojima, Aika, et al.
Publicado: (2013)

Multiple drugs: Prolonged course of COVID 19 infection and hypogammaglobulinaemia: case report
Publicado: (2022)

Refractory T-Cell Anergy and Rapidly Fatal Progressive Multifocal Leukoencephalopathy After Prolonged CTLA4 Therapy
por: Dekeyser, Manon, et al.
Publicado: (2017)

IRF4 haploinsufficiency in a family with Whipple’s disease
por: Guérin, Antoine, et al.
Publicado: (2018)

Stimulating severe COVID-19: the potential role of GM-CSF antagonism
por: Leavis, Helen L, et al.
Publicado: (2022)

FOXP3 and CTLA-4 genetic variants' influence on the susceptibility and clinical course of basal cell carcinoma
por: Sławińska, Martyna, et al.
Publicado: (2020)

Clinical Courses of IKAROS and CTLA4 Deficiencies: A Systematic Literature Review and Retrospective Longitudinal Study
por: Hoshino, Akihiro, et al.
Publicado: (2022)

Smad4 haploinsufficiency: a matter of dosage
por: Alberici, Paola, et al.
Publicado: (2008)

Blood PD-1(+)TFh and CTLA-4(+)CD4(+) T cells predict remission after CTLA-4Ig treatment in early rheumatoid arthritis
por: Aldridge, Jonathan, et al.
Publicado: (2021)

CTLA-4 as a genetic determinant in autoimmune Addison’s disease
por: Wolff, A S B, et al.
Publicado: (2015)

Lack of association between sCTLA-4 levels in human plasma and common CTLA-4 polymorphisms
por: Berry, Andrew, et al.
Publicado: (2008)

Expression of PD‐L1 and CTLA‐4 in female urethral carcinoma
por: Ninomiya, Sahoko, et al.
Publicado: (2018)

CTLA-4: From conflict to clinic
por: Bashyam, Hema
Publicado: (2007)

The role of CTLA-4 in immune regulation
por: Verhagen, Johan, et al.
Publicado: (2008)

Effects of Prolonged GRP78 Haploinsufficiency on Organ Homeostasis, Behavior, Cancer and Chemotoxic Resistance in Aged Mice
por: Lee, Amy S., et al.
Publicado: (2017)

Short Stature Homeobox-Containing Haploinsufficiency in Seven Siblings with Short Stature
por: Sandberg, Elizabeth S., et al.
Publicado: (2017)

Activated CTLA‐4‐independent immunosuppression of Treg cells disturbs CTLA‐4 blockade‐mediated antitumor immunity
por: Watanabe, Tomofumi, et al.
Publicado: (2023)

Functional Relevance of CTLA4 Variants: an Upgraded Approach to Assess CTLA4-Dependent Transendocytosis by Flow Cytometry
por: Rojas-Restrepo, Jessica, et al.
Publicado: (2023)

Effect of stem cell transplantation for B-cell malignancies on disease course of associated polyneuropathy
por: Stork, A. C. J., et al.
Publicado: (2012)

CNS demyelination associated with immune dysregulation and a novel CTLA-4 variant
por: Kaninia, Stefania, et al.
Publicado: (2021)

SMAD4 haploinsufficiency in small intestinal neuroendocrine tumors
por: Hofving, Tobias, et al.
Publicado: (2021)

Successful Treatment of Granulomatous-lymphocytic Interstitial Lung Disease in a Patient with CTLA-4 Deficiency
por: Nishimura, Masashi, et al.
Publicado: (2022)

Prolonged, Low-Dose Anti-Thymocyte Globulin, Combined with CTLA4-Ig, Promotes Engraftment in a Stringent Transplant Model
por: D’Addio, Francesca, et al.
Publicado: (2013)

PTEN haploinsufficiency and hemangiosarcoma
Publicado: (2012)

CTLA-4: a negative regulator of autoimmune disease
Publicado: (1996)

Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies
por: Peggs, Karl S., et al.
Publicado: (2009)

CTLA-4 Insufficiency due to a Novel CTLA-4 Deletion, Identified through Copy Number Variation Analysis
por: Olfe, Lisa, et al.
Publicado: (2022)

Correction to: Functional Relevance of CTLA4 Variants: an Upgraded Approach to Assess CTLA4‑Dependent Transendocytosis by Flow Cytometry
por: Rojas‑Restrepo, Jessica, et al.
Publicado: (2023)

QTc Prolongation in COVID-19 Patients Using Chloroquine
por: Becker, Matthijs L., et al.
Publicado: (2021)

Downregulation of sCD40 and sCTLA4 in Recovered COVID-19 Patients with Comorbidities
por: Méndez-Frausto, Gwendolyne, et al.
Publicado: (2022)

A case report of Grover’s disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1
por: Uemura, Marc, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_kbivoe0affmjp4elcjptj4jg0d